IRADIMED CORPORATION
1025 Willa Springs Drive
Winter Springs, Florida 32708

VIA EDGAR

May 6, 2024

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street NE

Washington, D.C. 20549

Attn:	Mr. Nicholas O’Leary
Re:	Iradimed Corporation
	Registration Statement on Form S-3/A
	File No. 333-278487

Acceleration Request

	Requested Date:	May 8, 2024
	Requested Time:	4:30 p.m. Eastern Time (or as soon thereafter as practicable)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, IRADIMED CORPORATION, a Delaware corporation (the “Registrant”), hereby requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3/A to become effective on May 8, 2024 at 4:30 p.m. Eastern Time, or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes K&L Gates LLP, counsel to the Registrant, to orally modify or withdraw this request for acceleration.

The Registrant requests that it be notified of such effectiveness by a telephone call to our counsel, K&L Gates LLP, by calling Mr. David A. Bartz at (615) 780-6743.


		Sincerely,

		IRADIMED CORPORATION

		By:	/s/ Roger Susi
			Roger Susi
			President, Chief Executive Officer and Chairman of the Board of Directors

cc:	David A. Bartz, K&L Gates LLP
	Leib Orlanski, K&L Gates LLP
	Zidong Liu, K&L Gates LLP